Cognitive Change Clinical Trial
— OYSACOOfficial title:
A Randomized Controlled Trial to Investigate the Neurological, Inflammatory and Metabolic Effects of Acute Mushroom Intervention in Older Adults (OYSACO)
NCT number | NCT05594329 |
Other study ID # | 22/10 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | August 15, 2022 |
Est. completion date | December 22, 2022 |
Verified date | May 2023 |
Source | University of Reading |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This randomized crossover trial (RCT) investigates the acute effect (over a 6-hour period) of a meal containing varying serving sizes (doses) of freeze-dried oyster mushroom powder, on the cognitive behaviour and markers of metabolism and inflammation related to neuronal health in healthy adults aged 60-80 years old. The study will involve a screening visit and four testing visits, with a week interval between each. During the four testing visits, cognitive-mood battery tests will be taken at baseline and then at 2-, 4- and 6-hour intervals following the consumption of the intervention meal. Also, a blood draw will be taken at the end of each testing visit day to allow the determination of inflammatory, metabolic and neuronal markers.
Status | Completed |
Enrollment | 33 |
Est. completion date | December 22, 2022 |
Est. primary completion date | December 1, 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 60 Years to 80 Years |
Eligibility | Inclusion Criteria: - Aged between 60-80 years old - Have normal vision and hearing - Have healthy status - Have a BMI<30 Exclusion Criteria: - Smokers or those consuming more than the recommended units of alcohol per week - Vegetarians/ Vegans - Being diagnosed with any psychiatric or neurologic conditions (e.g. schizophrenia, depression, cognitive dementia) - Being diagnosed with cardiometabolic disease (including type II diabetes and cardiovascular disease), or suffer from hypertension or thrombosis related disorders - Being anaemic - Currently taking regular vitamin supplements or disease medication such as anticoagulant or antiplatelet medication and antidepressants etc - Diagnosed with an eating disorder - Be allergic to mushrooms, or any other nutrients present in the intervention meals |
Country | Name | City | State |
---|---|---|---|
United Kingdom | University of Reading | Reading | Berkshire |
Lead Sponsor | Collaborator |
---|---|
University of Reading | Mushroom Council |
United Kingdom,
Ba DM, Gao X, Al-Shaar L, Muscat J, Chinchilli VM, Ssentongo P, Beelman RB, Richie J. Mushroom intake and cognitive performance among US older adults: the National Health and Nutrition Examination Survey, 2011-2014. Br J Nutr. 2022 Dec 14;128(11):2241-2248. doi: 10.1017/S0007114521005195. Epub 2022 Feb 4. — View Citation
Bingham S, Luben R, Welch A, Low YL, Khaw KT, Wareham N, Day N. Associations between dietary methods and biomarkers, and between fruits and vegetables and risk of ischaemic heart disease, in the EPIC Norfolk Cohort Study. Int J Epidemiol. 2008 Oct;37(5):978-87. doi: 10.1093/ije/dyn111. Epub 2008 Jun 25. — View Citation
Dicks L, Jakobs L, Sari M, Hambitzer R, Ludwig N, Simon MC, Stehle P, Stoffel-Wagner B, Helfrich HP, Ahlborn J, Ruhl M, Hartmann B, Holst JJ, Ellinger S. Fortifying a meal with oyster mushroom powder beneficially affects postprandial glucagon-like peptide-1, non-esterified free fatty acids and hunger sensation in adults with impaired glucose tolerance: a double-blind randomized controlled crossover trial. Eur J Nutr. 2022 Mar;61(2):687-701. doi: 10.1007/s00394-021-02674-1. Epub 2021 Sep 10. — View Citation
Gregory J, Vengalasetti YV, Bredesen DE, Rao RV. Neuroprotective Herbs for the Management of Alzheimer's Disease. Biomolecules. 2021 Apr 8;11(4):543. doi: 10.3390/biom11040543. — View Citation
Kleftaki SA, Simati S, Amerikanou C, Gioxari A, Tzavara C, Zervakis GI, Kalogeropoulos N, Kokkinos A, Kaliora AC. Pleurotus eryngii improves postprandial glycaemia, hunger and fullness perception, and enhances ghrelin suppression in people with metabolically unhealthy obesity. Pharmacol Res. 2022 Jan;175:105979. doi: 10.1016/j.phrs.2021.105979. Epub 2021 Nov 16. — View Citation
Rahman MA, Abdullah N, Aminudin N. Interpretation of mushroom as a common therapeutic agent for Alzheimer's disease and cardiovascular diseases. Crit Rev Biotechnol. 2016 Dec;36(6):1131-1142. doi: 10.3109/07388551.2015.1100585. Epub 2015 Oct 30. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Health and Lifestyle Questionnaire | This online survey includes basic demographic questions (eg age, sex, heigh, weight, nationality, disease history and medication use). | Baseline | |
Other | Epic-Norfolk Food Frequency Questionnaire (FFQ) | The FFQ is a validated tool for gauging the average habitual dietary intake of micro and macronutrients of an individual in the UK. Data will be processed using the FETA software. | Baseline | |
Other | Specialised dietary survey | Short survey relating to mushroom habitual intake. | 6-hours post-intervention on final test day | |
Primary | Change in Positive and Negative Affect Schedule (PANAS-SF) performance | In this validated self-reported mood task, participants are asked to rate their emotion. The PANAS comprises of two distinct affective states (positive and negative), as well as 11 individual affective states (fear, guilt, sadness, surprise, hostility, shyness, joviality, self-assurance, attentiveness, fatigue and serenity). Subjects use a likert scale from 1 - 5 to indicate how the word relates to how they are currently feeling. As this analysis is exploratory all affective states will be explored. | 2-hours post-intervention | |
Primary | Change in Positive and Negative Affect Schedule (PANAS-SF) performance | In this validated self-reported mood task, participants are asked to rate their emotion. The PANAS comprises of two distinct affective states (positive and negative), as well as 11 individual affective states (fear, guilt, sadness, surprise, hostility, shyness, joviality, self-assurance, attentiveness, fatigue and serenity). Subjects use a likert scale from 1 - 5 to indicate how the word relates to how they are currently feeling. As this analysis is exploratory all affective states will be explored. | 4-hours post-intervention | |
Primary | Change in Positive and Negative Affect Schedule (PANAS-SF) performance | In this validated self-reported mood task, participants are asked to rate their emotion. The PANAS comprises of two distinct affective states (positive and negative), as well as 11 individual affective states (fear, guilt, sadness, surprise, hostility, shyness, joviality, self-assurance, attentiveness, fatigue and serenity). Subjects use a likert scale from 1 - 5 to indicate how the word relates to how they are currently feeling. As this analysis is exploratory all affective states will be explored. | 6-hours post-intervention | |
Primary | Change in Immediate Word Recall performance from the Rey Auditory Verbal Learning Task (RAVLT) | This episodic memory task consists of 5 consecutive free recalls of the same 15 nouns presented as an auditory list (list A), followed by recall of a further 15 nouns presented as an interference list (list B) which is recalled only once. List A is subsequently recalled straight after list B and then again after a longer delay of around 30 minutes. | 2-hours post-intervention | |
Primary | Change in Immediate Word Recall performance from the Rey Auditory Verbal Learning Task (RAVLT) | This episodic memory task consists of 5 consecutive free recalls of the same 15 nouns presented as an auditory list (list A), followed by recall of a further 15 nouns presented as an interference list (list B) which is recalled only once. List A is subsequently recalled straight after list B and then again after a longer delay of around 30 minutes. | 4-hours post-intervention | |
Primary | Change in Immediate Word Recall performance from the Rey Auditory Verbal Learning Task (RAVLT) | This episodic memory task consists of 5 consecutive free recalls of the same 15 nouns presented as an auditory list (list A), followed by recall of a further 15 nouns presented as an interference list (list B) which is recalled only once. List A is subsequently recalled straight after list B and then again after a longer delay of around 30 minutes. | 6-hours post-intervention | |
Primary | Change in Corsi Block Tapping Test (CBTT) performance | In this spatial working memory task, participants are shown with 9 arranged blocks positioned on a computer screen and are asked to reproduce a given sequence by clicking on the blocks (using the mouse) in the same sequence as they see them. | 2-hours post-intervention | |
Primary | Change in Corsi Block Tapping Test (CBTT) performance | In this spatial working memory task, participants are shown with 9 arranged blocks positioned on a computer screen and are asked to reproduce a given sequence by clicking on the blocks (using the mouse) in the same sequence as they see them. | 4-hours post-intervention | |
Primary | Change in Corsi Block Tapping Test (CBTT) performance | In this spatial working memory task, participants are shown with 9 arranged blocks positioned on a computer screen and are asked to reproduce a given sequence by clicking on the blocks (using the mouse) in the same sequence as they see them. | 6-hours post-intervention | |
Primary | Change in Simple and complex finger tapping task (SFTT & CFTT) performance | In this motor function task, participants tap on a key as quickly as possible with the index finger of their dominant hand for 1 minute. They then tap out a specific sequence using 4 fingers, again for 1 minute. | 2-hours post-intervention | |
Primary | Change in Simple and complex finger tapping task (SFTT & CFTT) performance | In this motor function task, participants tap on a key as quickly as possible with the index finger of their dominant hand for 1 minute. They then tap out a specific sequence using 4 fingers, again for 1 minute. | 4-hours post-intervention | |
Primary | Change in Simple and complex finger tapping task (SFTT & CFTT) performance | In this motor function task, participants tap on a key as quickly as possible with the index finger of their dominant hand for 1 minute. They then tap out a specific sequence using 4 fingers, again for 1 minute. | 6-hours post-intervention | |
Primary | Change in the Task Switching Task (TST) performance | In this executive function task, participants view 8 spaced radii of a circle above and below a bold line and a stimulus digit selected from 1-9 (except 5) appears clockwise in each segment, either above or below the bold line. Depending on the stimulus position in the segments, participants perform different tasks with each being switched in every 4 trials. A response of higher or lower than 5 is made for trials below the bold line, and even or odd for numbers above the line. Outcome measures include overall accuracy and reaction time (RT) on correct trials, as well as accuracy and RT on trials where there is a 'switch cost' from stimuli moving from below to above the bold line and vice versa. | 2-hours post-intervention | |
Primary | Change in the Task Switching Task (TST) performance | In this executive function task, participants view 8 spaced radii of a circle above and below a bold line and a stimulus digit selected from 1-9 (except 5) appears clockwise in each segment, either above or below the bold line. Depending on the stimulus position in the segments, participants perform different tasks with each being switched in every 4 trials. A response of higher or lower than 5 is made for trials below the bold line, and even or odd for numbers above the line. Outcome measures include overall accuracy and reaction time (RT) on correct trials, as well as accuracy and RT on trials where there is a 'switch cost' from stimuli moving from below to above the bold line and vice versa. | 4-hours post-intervention | |
Primary | Change in the Task Switching Task (TST) performance | In this executive function task, participants view 8 spaced radii of a circle above and below a bold line and a stimulus digit selected from 1-9 (except 5) appears clockwise in each segment, either above or below the bold line. Depending on the stimulus position in the segments, participants perform different tasks with each being switched in every 4 trials. A response of higher or lower than 5 is made for trials below the bold line, and even or odd for numbers above the line. Outcome measures include overall accuracy and reaction time (RT) on correct trials, as well as accuracy and RT on trials where there is a 'switch cost' from stimuli moving from below to above the bold line and vice versa. | 6-hours post-intervention | |
Primary | Change in RAVLT - Delayed Word Recall performance | After a period of time subject are asked to recall as many words as possible from list A. | 2-hours post-intervention | |
Primary | Change in RAVLT - Delayed Word Recall performance | After a period of time subject are asked to recall as many words as possible from list A. | 4-hours post-intervention | |
Primary | Change in RAVLT - Delayed Word Recall performance | After a period of time subject are asked to recall as many words as possible from list A. | 6-hours post-intervention | |
Primary | Change in RAVLT - Word Recognition performance | Following the delayed word recall, words from list A, list B and novel words are displayed sequentially on the screen and participants are asked to indicate which words were from list A only. | 2-hours post-intervention | |
Primary | Change in RAVLT - Word Recognition performance | Following the delayed word recall, words from list A, list B and novel words are displayed sequentially on the screen and participants are asked to indicate which words were from list A only. | 4-hours post-intervention | |
Primary | Change in RAVLT - Word Recognition performance | Following the delayed word recall, words from list A, list B and novel words are displayed sequentially on the screen and participants are asked to indicate which words were from list A only. | 6-hours post-intervention | |
Secondary | Visual analogue measure of hunger, satiety, fullness, and prospective food consumption | Satiety Measure recorded on a 100 millimetre scale. Scores closer to 0 millimetres indicate less hunger, less satiety and less fullness - taken as a negative outcome, and less desire for prospective food consumption or consume something sweet, salty, savoury or fatty - taken as a positive outcome. | Baseline | |
Secondary | Visual analogue measure of hunger, satiety, fullness, and prospective food consumption | Satiety Measure recorded on a 100 millimetre scale. Scores closer to 0 millimetres indicate less hunger, less satiety and less fullness - taken as a negative outcome, and less desire for prospective food consumption or consume something sweet, salty, savoury or fatty - taken as a positive outcome. | 2-hours post-intervention | |
Secondary | Visual analogue measure of hunger, satiety, fullness, and prospective food consumption | Satiety Measure recorded on a 100 millimetre scale. Scores closer to 0 millimetres indicate less hunger, less satiety and less fullness - taken as a negative outcome, and less desire for prospective food consumption or consume something sweet, salty, savoury or fatty - taken as a positive outcome. | 4-hours post-intervention | |
Secondary | Visual analogue measure of hunger, satiety, fullness, and prospective food consumption | Satiety Measure recorded on a 100 millimetre scale. Scores closer to 0 millimetres indicate less hunger, less satiety and less fullness - taken as a negative outcome, and less desire for prospective food consumption or consume something sweet, salty, savoury or fatty - taken as a positive outcome. | 6-hours post-intervention | |
Secondary | Visual analogue measure of palatability of the intervention meal | Palatability Measure recorded on a 100 millimetre scale. Scores closer to 0 millimetres indicate good visual appeal, good smell, good taste and good overall palatability - taken as a positive outcome. | 1-hour post-intervention | |
Secondary | Neurotrophic marker | Blood serum levels of BDNF. | 6-hours post-intervention | |
Secondary | Metabolic marker- Glucose | Blood serum levels of glucose | 6-hours post-intervention | |
Secondary | Metabolic marker- Insulin | Blood serum levels of insulin | 6-hours post-intervention | |
Secondary | Metabolic marker- Triglycerides | Blood serum levels of triglycerides (TAG) | 6-hours post-intervention | |
Secondary | Inflammatory marker | Blood serum levels of Interleukin-6 (IL-6) | 6-hours post-intervention |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05712005 -
Cognitive Testing in Diverse Populations to Further the Objective and Clinical Understanding of Cognivue Study
|
||
Completed |
NCT05343208 -
Effectiveness of Online Therapy to Prevent Burnout
|
N/A | |
Active, not recruiting |
NCT05143294 -
Conectar Jugando: Board Games in Elementary Classrooms (6-12 Years Old) to Improve Executive Functions
|
N/A | |
Completed |
NCT05267730 -
Conectar Jugando: Board Games in Rural Elementary Classrooms (6-12 Years Old) to Improve Executive Functions
|
N/A | |
Completed |
NCT03987477 -
Online Intervention to Modify Interpretation Biases in Depression
|
N/A | |
Completed |
NCT03695003 -
Cognitive Effects of Sage in Healthy Humans
|
N/A | |
Completed |
NCT05075850 -
Multicenter Sub-study for LAANTERN Registry NCT02392078 That Will Include Comprehensive Neuropsychological Assessment Data Collection
|
||
Recruiting |
NCT05273996 -
Predictors of Cognitive Outcomes in Geriatric Depression
|
Phase 4 | |
Completed |
NCT03689348 -
Acute and Chronic Effects of Avena Sativa on Cognition and Stress
|
N/A | |
Completed |
NCT03674281 -
The VRIF Trial: Hypoglycemia Reduction With Automated-Insulin Delivery System
|
N/A | |
Active, not recruiting |
NCT05229705 -
Exercise in Older Adults at Risk for Type 2 Diabetes
|
N/A | |
Suspended |
NCT05001789 -
Cognitive Functioning in Opioid Use Disorder
|
N/A | |
Terminated |
NCT03337282 -
Incidence and Characteristics of Postoperative Cognitive Dysfunction in Elderly Quebec Francophone Patients
|
||
Recruiting |
NCT05014399 -
Cognitive Impairment in Colorectal Cancer Patients Receiving Cytotoxic Chemotherapy
|
||
Completed |
NCT03657537 -
Effects of Ketone Bodies on Cognition in Type 2 Diabetes
|
Phase 1 | |
Completed |
NCT05543811 -
The Influence of Food for Special Dietary Use - Spread Enriched With 5-hydroxytryptophan, Theanine and Gamma-aminobutyric Acid on Psychophysiological Functions of Subjects Without Meaningful Organic and Cognitive Pathology
|
N/A | |
Recruiting |
NCT05699226 -
Amplitude Titration to Improve ECT Clinical Outcomes
|
N/A | |
Recruiting |
NCT05026541 -
Resilience to Sleep Deprivation and Changes in Sleep Architecture in Shoonya Meditators
|
N/A | |
Active, not recruiting |
NCT03255499 -
Efficacy of the MovinCog Intervention in Children
|
N/A | |
Not yet recruiting |
NCT06252376 -
Effects of Blood Pressure on Cognition and Cerebral Hemodynamics in PD
|
N/A |